Navigation Links
Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
Date:2/2/2009

cs License Application (BLA) with the FDA in the second quarter of 2009. HGS will receive an additional $15 million from the U.S. Government upon FDA licensure of ABthrax.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer. The Company's primary focus is rapid progress toward the commercialization of its two key lead drugs, Albuferon(R) (albinterferon alfa-2b) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Phase 3 clinical trials of both drugs are ongoing. ABthrax(TM) (raxibacumab) is in late-stage development for inhalation anthrax, and HGS also has three drugs in clinical development for the treatment of cancer, including two TRAIL receptor antibodies and a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins. In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, which GSK has advanced to Phase 3 development as a potential treatment for coronary heart disease.

For more information about HGS, please visit the Company's web site at www.hgsi.com. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to clinical_trials@hgsi.com or by calling HGS at (301) 610-5790, extension 3550.

For an Electronic Press Kit on this announcement, please click here: http://www.firstlinemedia.com/epk/hgs/.

HGS, Human Genome Sciences, ABthrax, Albuferon and LymphoStat-B ar
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
2. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
3. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
4. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
5. 2008 Human Research Protection Award Recipients Announced
6. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
7. Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
8. SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial
9. GeoVaxs Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
10. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
11. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  (MUSE Booth ... Electronic Health Record (EHR) is invaluable in any ... EHRs are now a requirement and mainstream in ... continuously into the EHR is gaining traction in ... William Holmes, RN, Site Project Manager & Clinical ...
(Date:5/21/2015)... , 21. Mai 2015 /PRNewswire/ ... DPRX ), ein Unternehmen für Arzneimittel ... die Entwicklung und Vermarktung von Locilex® ... kündigte heute eine wissenschaftliche Posterpräsentation an, ... des Unternehmens vorstellt, OneStep-1 und OneStep-2, ...
(Date:5/21/2015)... May 21, 2015  Heidrick & Struggles (Nasdaq: ... , leadership consulting and culture shaping ... among global practices announcing the addition of Tim ... office. Dietlin has extensive life ... and across R&D, Medical and Commercial functions to increase ...
Breaking Medicine Technology:Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7Heidrick Increases Healthcare and Life Sciences Expertise 2
... REDWOOD CITY, Calif., Oct. 19 Ingenuity® Systems, ... science researchers, and TransMed Systems, a translational medicine ... between IPA® software and XB Bio-Integration Suite (XB-BIS). ... data that is managed and statistically analyzed by ...
... Results From the Intermezzo® Highway Driving Study -- POINT RICHMOND, Calif., Oct. 19 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // ...
Cached Medicine Technology:Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research 2Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 2Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 3Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 4Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 5Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 6Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 7Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 8Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 9Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 10Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 11Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 12Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 13Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 14
(Date:5/23/2015)... On May 16, the team at Farrell’s ... 5k mud obstacle run that raised funds for multiple sclerosis. ... and the reason we participated was to support people living ... Farrell’s eXtreme Bodyshaping. “One-hundred percent of the funds raised go ... was not only attended by eXtreme Bodyshaping staff, but members ...
(Date:5/23/2015)... Javon Bea Mercy Health System CEO ... Rehabilitation Center, 557 N. Washington St., Janesville, will host ... 5:30-6:30 pm. , The 8-week clinic is lead by ... BSN, who will offer training that encompasses a warm-up, ... and show selection and weekly training plans. , The ...
(Date:5/22/2015)... The world is at a "hinge ... to create new opportunities for leadership in health ... WesternU's 34th annual Commencement Exercises said Wednesday, May ... former San Francisco mayor and likely 2018 gubernatorial ... ceremony for WesternU's colleges of Allied Health Professions ...
(Date:5/22/2015)... Utah (PRWEB) May 22, 2015 Mountain Point ... host a ribbon cutting ceremony on Friday, May 29, 2015 ... p.m. to 6 p.m. The new medical center, set to ... North Triumph Boulevard, Lehi, UT 84043. , “The opening ... our team and the Utah County community,” said Kent Loosle, ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Following yesterday’s ... sale agreement with US-based health brand Nature’s Way, Marc ... brand. Retention of Ascenta Skin is an integral part ... excited about this opportunity to further develop Ascenta Skin ... , Ascenta Skin is a breakthrough, anti-aging skincare supplement ...
Breaking Medicine News(10 mins):Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2
... India is on high alert to tackle any Bird Flu ... Institute of Medical Sciences (AIIMS)' and another 20// bedded ward ... to treat any of the patients with avian influenza or ... has been the instruction to food restaurant in the city ...
... a world-class cancer hospital and research center, Tata Medical Centre ... cost of Rs. 1.2 billion. ,The cancer hospital known ... a 10-acre plot, West Bengal Chief Minister Buddhadeb Bhattacharjee and ... stone for the project scheduled to be completed by December ...
... to the news that that bird flu was found in chickens in ... ,The change has affected Leong Hup, Farm's Best and CAB// Cakaran ... to RM2.66 while Farm's Best shares and warrants lost 55 sen and ... sen to RM1.08. ,Among other poultry stocks, Lay ...
... can now be predicted by using a simple, non-invasive ... // The device measures the arterial stiffness and ... the heart. The results of the study can be ... ,More than 40% of Americans are at ...
... Mc Donald’s fried in another controversy which pertains to its ... filed in United States over its use of wheat and ... of contention is that these constituents might trigger allergy in ... of trans fat in a large serving of fries is ...
... blame all those people who had been telling you to ... for bone strength but is not the only one.,It works ... per a recent study which is part of Woman's Health ... supplements may not be effective in preventing osteoporosis in postmenopausal ...
Cached Medicine News:Health News:Heart Disease Risk Can Now Be Predicted By A Painless, Non-Invasive Test 2Health News:Calcium in isolation no good for maintaining bone integrity 2
... The Featured Products ... at Mediflex and are ... modular in regular or ... come equipped with insulation, ...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
... are offered as 1-piece or modular, in ... instruments may be customized with handles of ... insulation and flush ports. Many standard patterns ... may affect delivery times. , Please ...
Medicine Products: